165 related articles for article (PubMed ID: 34191114)
1. Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl
Yang J; Gong Y; Xu W; Li L; Shi Z; Wang Q; He Y; Zhang C; Luo C; Fang Z; Yang Y
Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1779-1786. PubMed ID: 34191114
[TBL] [Abstract][Full Text] [Related]
2. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
[TBL] [Abstract][Full Text] [Related]
4. Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis.
Gong Y; Li D; Li L; Yang J; Ding H; Zhang C; Wen G; Wu C; Fang Z; Hou S; Yang Y
Food Chem Toxicol; 2021 Jan; 147():111912. PubMed ID: 33290806
[TBL] [Abstract][Full Text] [Related]
5. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
6. Smad3 gene C-terminal phosphorylation site mutation aggravates CCl
Ding H; Fang M; Gong Y; Li D; Zhang C; Wen G; Wu C; Yang J; Yang Y
J Cell Mol Med; 2020 Jun; 24(12):7044-7054. PubMed ID: 32406200
[TBL] [Abstract][Full Text] [Related]
7. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.
Yoshida K; Murata M; Yamaguchi T; Matsuzaki K; Okazaki K
J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26771649
[TBL] [Abstract][Full Text] [Related]
8. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
10. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review).
Yoshida K; Murata M; Yamaguchi T; Matsuzaki K
Int J Oncol; 2014 Oct; 45(4):1363-71. PubMed ID: 25050845
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C.
Yamaguchi T; Matsuzaki K; Inokuchi R; Kawamura R; Yoshida K; Murata M; Fujisawa J; Fukushima N; Sata M; Kage M; Nakashima O; Tamori A; Kawada N; Tsuneyama K; Dooley S; Seki T; Okazaki K
Hepatol Res; 2013 Dec; 43(12):1327-42. PubMed ID: 23458062
[TBL] [Abstract][Full Text] [Related]
13. Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis.
Yoshida K; Matsuzaki K; Murata M; Yamaguchi T; Suwa K; Okazaki K
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29874844
[TBL] [Abstract][Full Text] [Related]
14. Smad2 protects against TGF-β1/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis.
Zhang L; Liu C; Meng XM; Huang C; Xu F; Li J
Mol Cell Biochem; 2015 Feb; 400(1-2):17-28. PubMed ID: 25351340
[TBL] [Abstract][Full Text] [Related]
15. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W
Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068
[TBL] [Abstract][Full Text] [Related]
17. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
Matsuzaki K
Histol Histopathol; 2006 Jun; 21(6):645-62. PubMed ID: 16528675
[TBL] [Abstract][Full Text] [Related]
18. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
19. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.
Matsuzaki K
Cell Tissue Res; 2012 Jan; 347(1):225-43. PubMed ID: 21626291
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification, and evaluation of in vivo anti-fibrotic activity for soluble truncated TGF-β receptor II as a cleavable His-SUMO fusion protein.
Wang X; Li Y; Li X; Yan L; Guan H; Han R; Han Y; Gui J; Xu X; Dong Y; Liu H
World J Microbiol Biotechnol; 2018 Nov; 34(12):181. PubMed ID: 30474742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
